Company

Sensible Medical Innovations Ltd.

Sensible Medical Innovations Ltd. develops noninvasive heart failure monitoring, including the ReDS system for lung fluid measurement.

About

Founded in 2007 in Netanya, Israel, Sensible Medical Innovations Ltd. develops noninvasive monitoring technologies for heart failure and other chronic diseases. Its flagship ReDS (Remote Dielectric Sensing) system measures pulmonary congestion within 45 seconds and is sold to healthcare providers. The company raised USD 7.00 mn on November 11, 2013, with investments from Boston Scientific, Genesis Partners, SCP Vitalife Partners and Shanghai LongTec Medical Technology Co. Ltd. It has completed 2 deals and is at the Series A stage.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in